Foresite Capital Management II’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Foresite Capital Management II’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-717,133	Closed	-$3.8M	–	8
2019 Q1	$3.8M	Sell	717,133 -79,600	-10%	-$364K	1.72%	7
2018 Q4	$2.95M	Sell	796,733 -152,500	-16%	-$536K	1.56%	8
2018 Q3	$2.66M	Buy	949,233 +918,733	+3,012%	+$2.58M	0.98%	9
2018 Q2	$90K	Buy	+30,500	New	+$72.3K	0.03%	10
2016 Q4	–	Sell	-225,281	Closed	-$608K	–	11
2016 Q3	$608K	Sell	225,281 -109,958	-33%	-$279K	0.29%	10
2016 Q2	$791K	Sell	335,239 -408,156	-55%	-$1.13M	0.54%	15
2016 Q1	$2.4M	Sell	743,395 -204,420	-22%	-$755K	1.18%	15
2015 Q4	$4.54M	Buy	947,815 +66,253	+8%	+$376K	1.52%	14
2015 Q3	$4.9M	Buy	881,562 +169,284	+24%	+$1.25M	1.49%	14
2015 Q2	$5.67M	Buy	712,278 +264,400	+59%	+$2.27M	1.99%	12
2015 Q1	$4.7M	Buy	447,878 +54,195	+14%	+$740K	2.79%	11
2014 Q4	$4.73M	Buy	+393,683	New	+$5.98M	3.24%	11

Other funds holding BDSI

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Foresite Capital Management II's BDSI Position: Q2 2019 in Review

Foresite Capital Management II sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2019, closing a stake of 717,133 shares — an estimated $3.8M sold.

Foresite Capital Management II first reported a position in BDSI in Q4 2014 and held it in 12 quarters. The position peaked at $5.67M in Q2 2015. 110 funds tracked by Wall St. Rank hold BDSI as of Q2 2019.

Foresite Capital Management II reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2019 after selling out during the quarter.
Foresite Capital Management II sold 717,133 BioDelivery Sciences International, Inc. shares in Q2 2019, an estimated $3.8M.
Foresite Capital Management II first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 12 quarters.
Foresite Capital Management II's BioDelivery Sciences International, Inc. position peaked at $5.67M in Q2 2015.
110 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2019.

Based on Foresite Capital Management II's 13F filing for Q2 2019, filed 13 Aug 2019.